Astellas is ready to launch its first digital ... The companies are now hoping to sell the platform to commercial health programmes in the US. The patient monitoring platform puts heart failure ...

The company said in its third-quarter results call that it is already building commercial manufacturing capacity for zolbetuximab as it anticipates the readout of the two phase 3 trials. Astellas ...

But a novel strategy used by Astellas Pharma Inc., a pharmaceutical company based in Japan, exploits the body’s own molecular trash-disposal system to address problematic proteins. Around 80% of ...